PetMed Express, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by PetMed Express, Inc. on May 15, 2026. The report addresses corporate governance matters specifically regarding the scheduling of the 2026 Annual Meeting of Shareholders and the associated deadlines for shareholder proposals and director nominations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics. This report is limited to corporate governance notifications.
Material Changes
The primary material change disclosed is the rescheduling of the 2026 Annual Meeting of Shareholders. The meeting is now set to be held virtually on August 11, 2026. This date represents a change of more than 30 days from the anniversary of the 2025 Annual Meeting, which invalidates previous submission deadlines for shareholder proposals and director nominations.
Guidance, Outlook, and Management Commentary
Management has announced that the 2026 Annual Meeting will be conducted virtually. The filing details the new deadlines for shareholders to submit proposals and nominations:
- Rule 14a-8 Proposals: Must be received by May 31, 2026.
- Proxy Access Director Nominations: Notices must be received by May 31, 2026.
- Other Proposals/Nominations: Notices for proposals outside Rule 14a-8 or other director nominations must be received by May 31, 2026.
The filing explicitly states that any adjournment or postponement of the meeting will not extend these submission periods.
Key Facts for Investor Verification
- Verify the virtual meeting date of August 11, 2026, in the upcoming Definitive Proxy Statement (Schedule 14A).
- Confirm the May 31, 2026, deadline for submitting shareholder proposals and director nominations to the Corporate Secretary.
- Note that the filing contains no financial performance data or guidance updates.